Please wait...
About This Project
Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Dermatology AI Assistant to Empower Primary Care Providers in Zaatari Refugee Camp in Jordan
An AI-assisted dermatology tool for refugees, utilizing imaging and symptom questionnaires to improve diagnostic...
Detection of Zika virus rapidly without the need for a laboratory in Brazil
Zika (PORTUGUESE) is a rapidly emerging pandemic, a global health emergency. ZIKV has been associated with...
Part 2: Can low carbohydrate ketogenic diets inhibit cancers?
We've identified that ketone bodies, i.e. fuels in the bloodstream that result from a very low carbohydrate...